FDA acting chief says two journal articles by former commissioner do not represent agency policy

Acting FDA Commissioner Kyle Diamantas announced that the agency is reversing its earlier position regarding two medical‑journal articles authored by former commissioner Marty Makary.

The FDA now states that those articles, published over the past year, never constituted official FDA policy and should not be treated as such.

The clarification comes as part of a broader effort to unwind policy decisions linked to Makary’s tenure and to ensure that agency guidance is communicated through formal channels.